Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Tokyo Big Sight

Nov 10, 2019 9:30 AM - Nov 12, 2019 5:40 PM

3-11-1 Ariake, Koto-ku, Tokyo, 135-0063 Japan

16th DIA Japan Annual Meeting 2019

Delivering Rational Medicine for All People in the Globe

[S28] Global Oncology Development - Be a Game Changer in Oncology Development -

Session Chair(s)

Hironobu  Saito, PhD

Hironobu Saito, PhD

Specially Appointed Professor

Tottori University, Chromosome Egineering Research Center, Japan

The world surrounding cancer treatment continues to evolve rapidly. New, emerging products include not only immuno-oncology drugs, but also regenerative medicine and medical devices, that expand the therapeutic choice in the field of cancer treatment. Thanks to the rapidly evlolving digital applications, artificial intelligence (AI), and the Internet of Things (IoT) that affect clinical trial operations, clinical development faces both challenge and opportunity to keep the evaluation of novel therapeutic products simple and reliable. This session provides a great opportunity to discuss how we can move towards ideal future direction of global clinical trial in oncology. This is a pre-session for DIA Global Oncology Development 2020 held on Jan 31, 2020.


Eri  Sekine

Opportunities for More Contribution to Clinical Trials

Eri Sekine

CMIC Group, Japan

Executive Vice President

Toshiko  Ishibashi, PhD, RN

Site Capability for Global Study - from Both “ Sites and Sponsors” Perspectives

Toshiko Ishibashi, PhD, RN

Daiichi Sankyo Co., Ltd., Japan

Oncology Medical Science Department, Medical Affairs Division

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.